Crop Life Science Ltd

Crop Life Scienc Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Crop Life Science Ltd

₹ 43.6 -3.33%
21 Nov - close price
croplifescience.com NSE - SME: CLSL
About

Incorporated in 2006, Crop Life Sciences
Ltd manufactures and deals in pesticides, insecticides, herbicide, fertilizers and allied products related to research and technical formulations[1]

Key Points

Business Overview:[1]
CLSL is an ISO 9001:2015 and ISO 14001:2004 certified manufacturer of crop protection chemicals, including Insecticides, Fungicides, Herbicides, Weedicides, Micro fertilizers, new generation organic Bio-stimulants, Bio-fertilizers, Bio-Pesticide’s plant growth regulators, and soil plant health products

Website NSE - SM
  • Market Cap ₹ 74.7 Cr.
  • Current Price ₹ 43.6
  • High / Low ₹ 69.2 / 36.5
  • Stock P/E 12.2
  • Book Value ₹ 43.9
  • Dividend Yield 0.00 %
  • ROCE 12.7 %
  • ROE 10.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.99 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 9.71% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024
79 52 97 101 106
75 45 91 95 98
Operating Profit 5 7 6 6 8
OPM % 6% 13% 7% 6% 8%
0 1 1 1 0
Interest 1 2 1 2 2
Depreciation 1 3 2 2 2
Profit before tax 2 3 4 4 4
Tax % 62% -1% 20% 32% 23%
1 3 3 3 3
EPS in Rs 0.78 2.61 1.96 1.56 2.01
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
126 107 94 130 191 207
118 98 86 118 178 193
Operating Profit 8 9 8 12 13 14
OPM % 7% 8% 8% 9% 7% 7%
0 1 0 1 2 1
Interest 2 2 2 3 3 4
Depreciation 2 3 2 4 3 3
Profit before tax 5 5 4 6 8 8
Tax % 30% 25% 25% 27% 26%
3 4 3 4 6 6
EPS in Rs 2.69 3.08 2.34 3.39 3.52 3.57
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 21%
TTM: 39%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 16%
TTM: -6%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 3%
Return on Equity
10 Years: %
5 Years: %
3 Years: 10%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 12 12 12 12 17 17
Reserves 18 21 24 29 55 58
16 18 22 27 34 44
31 35 37 34 67 110
Total Liabilities 76 86 95 102 173 229
12 13 11 16 22 21
CWIP 0 0 1 0 0 0
Investments 0 0 0 0 12 12
64 73 82 86 138 195
Total Assets 76 86 95 102 173 229

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
3 4 -0 2 -8
-1 -2 -2 -4 -16
-3 -1 1 1 24
Net Cash Flow -1 1 -1 -2 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 80 89 143 92 148
Inventory Days 93 159 137 104 99
Days Payable 72 108 137 79 131
Cash Conversion Cycle 100 140 143 116 117
Working Capital Days 93 125 169 145 135
ROCE % 14% 11% 14% 13%

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024Sep 2024
70.01% 70.01% 70.01%
30.00% 29.99% 29.99%
No. of Shareholders 2,0641,8581,602

Documents

Announcements

Annual reports